Biologics

Guy Cook is the CEO of Lattice Biologics.

Cellect Biotechnology received several patent grants for its Apograft technology.

OsteoRemedies launched the first FDA-cleared dual-antibiotic spacer system and bone cement offering with gentamicin and vancomycin.  

MTF Biologics and Academy Medical partnered to bring human allograft tissues to Veteran Affairs medical centers across the U.S.

ORTHOReBIRTH USA signed a letter of intent to develop new biologic products with Loubert Suddaby, MD.

The Tobra Medical Bone Basket is designed to help surgeons maximize the collection of autologous bone during drilling for bone graft.

Orthopedic surgeon Sunny Patel, MD, performed a new knee cartilage replacement procedure at Burlington, N.C.-based Alamance Regional Medical Center, the Times-News reports.

Biological Industries USA and StemExpress partnered to distribute StemExpress' human bone marrow-derived mesenchymal stem cells.

Cytokines present in umbilical cord blood-derived products can stimulate cellular processes necessary for bone regeneration, according to a study in Regenerative Medicine.

The global orthobiologics market is projected to reach $10.1 billion by 2025, according to Market Insights Reports.